$41.7m in revenue in December quarter $23m for March quarter. Doesn't look good at all ??? Customer acquisition cost looks expensive.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025